Date published:
Audience:
General public
AMRAB comprises experts from the health and medical research sector and highly regarded community representatives who have contributed to advancing Australian research.
AMRAB develops the Australian Medical Research and Innovation Priorities every 2 years to inform government decisions on MRFF investments. In finalising the 12 priorities for 2024–2026, AMRAB considered:
- the burden of disease on the Australian community
- how to deliver practical benefits from medical research and innovation to as many Australians as possible
- how to ensure the MRFF complements and enhances other forms of financial assistance for medical research and innovation.
AMRAB also took into consideration:
- better alignment with the Australian Medical Research and Innovation Strategy 2021–2026
- the National Health and Medical Research Council’s (NHMRC) health priorities for 2024–2027
- feedback from the 2023 consultation on the alignment and coordination of the MRFF and the NHMRC’s Medical Research Endowment Account
- stakeholder feedback from a consultation in September 2024.
Read the Australian Medical Research and Innovation Priorities 2024–2026.
Find out what stakeholders told us during the consultation.
Learn about the MRFF's strategy and priorities.